Cited by

• Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.

  Ledesma MD, Prinetti A, Sonnino S, Schuchman EH. Ledesma MD, et al. J Neurochem. 2011 Mar;116(5):779-88. doi: 10.1111/j.1471-4159.2010.07034.x. Epub 2011 Jan 7. J Neurochem. 2011. PMID: 21214563 Free PMC article. Review.
• Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.

  Minami K, Morimoto H, Morioka H, Imakiire A, Kinoshita M, Yamamoto R, Hirato T, Sonoda H. Minami K, et al. Int J Mol Sci. 2022 Oct 3;23(19):11724. doi: 10.3390/ijms231911724. Int J Mol Sci. 2022. PMID: 36233030 Free PMC article. Review.
• Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.

  Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF. Ohmi K, et al. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1902-7. doi: 10.1073/pnas.252784899. Epub 2003 Feb 7. Proc Natl Acad Sci U S A. 2003. PMID: 12576554 Free PMC article.
• Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.

  Pan D. Pan D. Curr Pharm Biotechnol. 2011 Jun;12(6):884-96. doi: 10.2174/138920111795542679. Curr Pharm Biotechnol. 2011. PMID: 21235445 Free PMC article. Review.
• Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.

  Huang W, Cheng YS, Yang S, Swaroop M, Xu M, Huang W, Zheng W. Huang W, et al. Exp Cell Res. 2021 Oct 1;407(1):112785. doi: 10.1016/j.yexcr.2021.112785. Epub 2021 Aug 16. Exp Cell Res. 2021. PMID: 34411609 Free PMC article.